FDA Limit on 23andMe Genetic Tests Called Unwarranted
Wednesday, January 15, 2014 - 14:30
in Health & Medicine
The Food and Drug Administration's recent action to stop the sale of genetic tests by the company 23andMe is unwarranted, according to scholars who argue that recent research shows such tests do not cause people distress, or encourage risky behavior.